List of Arbor Pharmaceuticals patents

List of Arbor Pharmaceuticals patents

List of ARINC patents

List of North China Electric Power University patents

List of View, Inc. patents

RPM Ventures Investment Funds

Founders educated at University of Deusto

Patents where

Current Assignee

Name

is

Arbor Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11413277 Non-aqueous liquid nimodipine compositions	Patent 11413277 was granted and assigned to Arbor Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	11413277	August 16, 2022
	‌ US Patent 11013703 Sotalol compositions and uses of the same	Patent 11013703 was granted and assigned to Arbor Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	11013703	May 25, 2021
	‌ US Patent 9724297 Sotalol compositions and uses of the same	Patent 9724297 was granted and assigned to Arbor Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.		Arbor Pharmaceuticals		United States Patent and Trademark Office	9724297	August 8, 2017
	‌ US Patent 11229621 Pharmaceutical compositions of dimethyl fumarate	Patent 11229621 was granted and assigned to Arbor Pharmaceuticals on January, 2022 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	11229621	January 25, 2022
	‌ US Patent 10179118 Pharmaceutical compositions of dimethyl fumarate	Patent 10179118 was granted and assigned to Arbor Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.		Arbor Pharmaceuticals		United States Patent and Trademark Office	10179118	January 15, 2019
	‌ US Patent 10940117 Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof	Patent 10940117 was granted and assigned to Arbor Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	10940117	March 9, 2021
	‌ US Patent 10576055 Pharmaceutical compositions of dimethyl fumarate	Patent 10576055 was granted and assigned to Arbor Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	10576055	March 3, 2020
	‌ US Patent 10385014 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use	Patent 10385014 was granted and assigned to Arbor Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	10385014	August 20, 2019
	‌ US Patent 10945984 Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects	Patent 10945984 was granted and assigned to Arbor Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	10945984	March 16, 2021
	‌ US Patent 10206895 Sotalol compositions and uses of the same	Patent 10206895 was granted and assigned to Arbor Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	10206895	February 19, 2019
	‌ US Patent 11229207 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice	Patent 11229207 was granted and assigned to Arbor Pharmaceuticals on January, 2022 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	11229207	January 25, 2022
	‌ US Patent 11135296 Pharmaceutical compositions of fumaric acid esters	Patent 11135296 was granted and assigned to Arbor Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	11135296	October 5, 2021
	‌ US Patent 10342787 Non-aqueous liquid nimodipine compositions	Patent 10342787 was granted and assigned to Arbor Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	10342787	July 9, 2019
	‌ US Patent 11207306 Non-aqueous liquid nimodipine compositions	Patent 11207306 was granted and assigned to Arbor Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.		Arbor Pharmaceuticals		United States Patent and Trademark Office	11207306	December 28, 2021
	‌ US Patent 10576070 Non-aqueous liquid nimodipine compositions	Patent 10576070 was granted and assigned to Arbor Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	10576070	March 3, 2020
	‌ US Patent 10716760 Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof			Arbor Pharmaceuticals		United States Patent and Trademark Office	10716760	July 21, 2020
	‌ US Patent 11938111 Pharmaceutical compositions of dimethyl fumarate	Patent 11938111 was granted and assigned to Arbor Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	11938111	March 26, 2024
	‌ US Patent 11850222 Sotalol compositions and uses of the same	Patent 11850222 was granted and assigned to Arbor Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Arbor Pharmaceuticals		United States Patent and Trademark Office	11850222	December 26, 2023

18 results

0 selected

18 results

0 selected